24/7 Wall Street
29 May 2026, 13:48 UTC · 5h ago
Source · https://247wallst.com/investing/2026/05/29/cant-buy-spacex-yet-wall-street-says-this-150-stock-is-the-next-best-thing-but-theres-a-catch/
Read source
Search tags
Story key points
5 claims · impact-rated
Rocket Lab's Q1 revenue rose 63.5% year-over-year to $200.35 million with non-GAAP gross margins expanding to 43.0%. — Strong top-line growth and margin expansion demonstrate fundamental operational improvement and scaling.
+0.60Rocket Lab is planning the debut of its Neutron medium-lift rocket in Q4 2026. — Success would place the company in a high-barrier medium-lift category, serving as a primary growth catalyst.
+0.50Rocket Lab currently trades at 121 times sales with a net loss of $198.2 million in fiscal 2025. — Extremely high valuation relative to revenue and persistent losses create significant downside risk if catalysts fail.
-0.50Rocket Lab has secured an $816 million Space Development Agency contract for 18 satellites and expanded its backlog to $2.20 billion. — Large government contracts and a growing backlog provide revenue visibility and validate its defense platform strategy.
Continue reading
6 related stories
The stock has become a proxy trade for a potential SpaceX IPO expected by June 2026. — Speculative retail demand is driving price action, though it introduces risk if the IPO cannibalizes proxy capital.
+0.20Ticker attribution
Model heads
Shares are reporting significant midday climbs of 8% and 20%.
Shares are reported to be up 15%.
Strong revenue growth, expanding margins, and significant backlog, though tempered by high valuation and net losses.
Impact vectors
8 dimensions · 9 clusters
Market reaction
10 bid · 10 offered
Schaeffers Research
3h ago
